$OREX Orexigen Therapeutics (OREX) Overall Average: 48% Buy.

An Impressive Revenue Achievement for KULR Technology Group KULR Technology Group, Inc. (NYSE American: KULR), a leader in sustainable energy management, has reported remarkable financial results for its third quarter, showcasing a trend of consistent growth and operational improvements. As the company navigates through the fast-evolving energy landscape, it remains...

Abeona Therapeutics Closes $155 Million Priority Review Voucher Deal Abeona Therapeutics Inc. (Nasdaq: ABEO) has made headlines by entering into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for an impressive $155 million. This substantial financial move marks a significant milestone for the company as they navigate the dynamics...

California BanCorp Reports Robust Second Quarter Earnings California BanCorp (NASDAQ: BCAL), the holding company for California Bank of Commerce, recently reported its financial performance for the second quarter, showcasing a solid net income of $14.1 million, translating to $0.43 per diluted share. Financial Highlights of Q2 2025 This impressive figure marks a decrease...

Starwood Property Trust, Inc. (NYSE: STWD) completed a $400 million private offering of 6.000% unsecured senior notes due in 2030 back in early 2024, a bold move that made waves on the trading floor. Priced at par value, this maneuver was significant for traders eyeing how such issuances could affect the company’s leverage and cash flow dynamics moving forward....

FrankSpeech Unveils New Features for Content Creators FrankSpeech is thrilled to announce the launch of exciting new features designed specifically for content creators. This latest initiative marks a significant advancement for the platform, focusing on enhancing video sharing, audience engagement, and monetization avenues. FrankSpeech is dedicated to creating an...